Filter
285
Filtered Results: 285
Text search:
Jiang,
N.
et
al.
Featured
Recommendations
31
New Publications
29
Language
Document type
No document type
83
Studies & Reports
82
Guidelines
82
Fact sheets
16
Manuals
13
Strategic & Response Plan
5
Training Material
2
Situation Updates
1
Resource Platforms
1
Countries / Regions
Global
20
Russia
12
Germany
10
Brazil
9
Latin America and the Carribbean
7
Africa
6
Middle East and North Africa
6
South Africa
6
India
5
Syria
4
Mozambique
4
Yemen
4
Angola
4
China
3
Guinea-Bissau
3
South–East Asia Region
3
Western and Central Europe
3
Ecuador
3
Nepal
2
Kenya
2
Sierra Leone
2
Peru
2
Philippines
2
USA
2
Asia
2
West and Central Africa
2
Eastern Europe and Central Asia
2
France
2
Spain
2
Vietnam
2
Eastern Europe
2
Colombia
1
Ghana
1
Chile
1
Nigeria
1
Italy
1
Venezuela
1
Congo, Democratic Republic of
1
Portugal
1
East and Southern Africa
1
Uganda
1
Sudan
1
Ethiopia
1
Indonesia
1
Myanmar / Burma
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
87
Clinical Guidelines
23
Public Health
21
Women & Child Health
9
Key Resources
7
Pharmacy & Technologies
5
Capacity Building
2
Toolboxes
COVID-19
99
Mental Health
25
Planetary Health
22
TB
14
HIV
13
NTDs
13
NCDs
12
Disability
7
Health Financing Toolbox
7
AMR
7
Caregiver
6
Pharmacy
6
Specific Hazards
4
Ebola & Marburg
4
Conflict
4
Rapid Response
3
Global Health Education
3
Zika
2
Refugee
1
The article discusses the significant impact of chronic obstructive pulmonary disease (COPD) as a global health issue, with cigarette smoking as the main risk factor. However, in developing countries, the causes of COPD are often multifactorial, involving environmental tobacco smoke, biomass fuel sm...
The growing understanding of how sequence information can contribute to improved public health is driving global investments in sequencing facilities and programmes. The falling cost and complexity of generating GSD provides opportunities for expanding sequencing capacity; however, challenges to wid...
There is no secret to our procedure: the daily scanning of the literature helps us to stay afloat in the never-ending waves of new publications about SARS-CoV-2 and COVID-19. Many papers discussed in the Top 10 will eventually make it into subsequent editions of COVID Reference.
This document provides interim guidance on the management of the blood supply in response to the pandemic outbreak of coronavirus disease (COVID-19). It emphasizes the importance of being prepared and responding quickly and outlines key actions and measures that the blood services should take to mit...
This document provides up-to-date guidance on laboratory studies as well as smallscale (semi-field) and large-scale field trials to assess the efficacy and determine field application rates of new molluscicide products for control of schistosomiasis.
Este documento apresenta uma orientação provisória aos laboratórios e diferentes atores envolvidos na realização de exames laboratoriais para o vírus COVID-19. Ele baseia-se parcialmente na orientação provisória para os exames laboratoriais do coronavírus da Síndrome Respiratória do Ori...
This publication outlines public health aspects of alcohol use and harm in WHO South East Asia Region Countries. It summarizes Global Regional and country specific data and also discusses aspects of alcohol control that are important in the context of the Region. The possible future trend of alcohol...
This brief summarizes current evidence and guidance for maintaining safe and effective care across the spectrum of maternal, newborn and infant care while protecting mother and child and health care providers during COVID-19. Furthermore, implications of the principle of “do no harm” are reviewe...
This Rapid Advice Guideline updates the Interim Guidance on the “Assessment of infants with microcephaly in the context of Zika virus” published in February 2016 (WHO/ZIKV/MOC/16.3). The recommendations provides guidance on the screening, clinical assessment, neuroimaging, laboratory investigati...
Orientação provisória. 2 de setembro de 2020
Questão clínica: Qual é o papel dos corticosteroides sistêmicos no tratamento de pacientes com COVID-19? Público-alvo: O público-alvo consiste principalmente de médicos, seguido por tomadores de decisão na área de saúde.
Prepared as an outcome of ICMR Subcommittee on Breast Cancer |.This consensus document on management of breast cancers summarizes the
modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular markers and research questions. It also inter...
3 March 2022
The WHO Therapeutics and COVID-19: living guideline contains the Organization’s most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an ...
Int J Health Geogr. 2002; 1: 5.
Published online 2002 Dec 20. doi: 10.1186/1476-072X-1-5
PMCID: PMC149400
PMID: 12537588
Stand 2.10.2020
Interim guidance 2 February 2021 . Available in Arabic, Chinese, English, French, Ukranian, Russian
Health workers are at the front line of the COVID-19 outbreak response and as such are exposed to different hazards that put them at risk. Occupational hazards include exposure to SARS-CoV-2 and othe...
Вариативные рекомендации 24 сентября 2021 г.
Этот документ представляет собой текущие рекомендации ВОЗ. В них будут вноситься изменения и дополнения,
касающиеся нов...
